Yves VERBOVEN
Senior Adviser - MedTech Europe
Implementation of HTA Regulation at Full Speed – What’s up and Will Countries use it?
Thursday 1 June 11:10 - 12:00
Europe’s Investment in Scientific Advice and Joint Scientific Consultations as Part of New Regulations MDR/IVDR/ HTA-R, New Pieces of the Puzzle !
Wednesday 31 May 15:00 - 15:50
Yves leads the Access & Economic Policies team we focus on European legislative and research initiatives in fields as procurement, health technology assessment, evidence generation representing the medtech industry view and deploying own initiatives striving to have a timely access for medical technologies and solutions and have these appropriately used and rewarded.
Yves has an applied science and engineering background with further education in Business administration and health economics. Yves considers the area of medical technologies which transfers the engineering world into something as good and valuable as health, a pre-requisite for well-being and happiness, a great motivator.
Together with the team his focus is not only on the health issue challenges but also to the health system challenges, to offer best care and to do this without waste, inefficiency, complication and see this incorporated into the policies when assessing medical technology. This supports a change to a value-based model of access and awarding of new medical technology value propositions.
In the medtech industry Yves has expertise in the field of clinical engineering, first in human studies, clinical and health economic outcomes trials and analysis, reimbursement, and then, after moving to MedTech Europe, with a focus on policies and advancing the medtech access model striving to a value-based access model, and having the appropriate instruments in place to award and reward the value of medical technology.
